Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.
The FDA approved the combination medicine of Trifluridine and Tipiracil in 2015 to treat patients with metastatic colorectal cancer and metastatic gastric or gastroesophageal junction adenocarcinoma. This combination medicine is sold under the brand name Lonsurf, and it is available in tablets in 15 mg Trifluridine/6.14 mg Tipiracil and 20 mg Trifluridine/8.19 mg. Trifluridine, a nucleoside metabolic inhibitor and Tipiracil hydrochloride, a thymidine phosphorylase inhibitor.
Trifluridine Tipiracil price is reasonable, and one can find this medicine with licensed generic medicine suppliers. Dial 18008891064 for more details about this combination medicine.
0
